Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 88.17

+3.2%

Jan 22 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2686)	5/12/2010 10:38:32 AM
From: Jibacoa	Read Replies (1) of 3722

ACHN was up 24.5% and it is still up 16.83% at present with volume of 240Ks already about 2x its ADV. It has scheduled a CC for 1:15pm today.:>) The stock opened with a good UG. bigcharts.marketwatch.com It reported yesterday additional preliminary data from its P1b of ACH-1625, which demonstrated that both the third and fourth patient cohorts receiving treatment with ACH-1625 achieved meaningful reductions in HCV RNA after five-day monotherapy, with continued safety and tolerability in patients with hepatitis C (HCV). ACH-1625 is an inhibitor of HCV NS3 protease that was discovered and is being developed by ACHN. ACHN said that they "remain very encouraged by these results and look forward to advancing the drug into a PII in the coming months." <g> The stock has already closed its Dec16 UG The next resistance is at the $3 level and then the Apr15H at $3.30 bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next